Lexalytics, a provider of text analytics solutions, has released the Pharmaceutical Industry Pack, created to meet the specific needs of market research, social media marketing, customer experience management (CEM) and voice of the customer (VOC) professionals in the pharmaceutical industry.
Leveraging Lexalytics' natural language processing (NLP) and machine learning (ML) technology, the Pharmaceutical Industry Pack helps pharmaceutical companies gain insights, such as identifying co-occurrences of medications, conditions, symptoms, and sentiment. The Pack will also uncover whether more patients have positive experiences at certain dosages of certain medications, and if patients are being prescribed medications for off-label symptoms.
Lexalytics combines out-of-the-box functionality with the ability to configure the platform. The Pharmaceutical Industry Pack comes with more than 1,000 user-defined entities relevant to pharmaceuticals, including the most common medications, symptoms, conditions, and diseases derived from sources such as the Centers for Disease Control and Prevention (CDC). The pack also includes named entity improvements, including anatomical references and two patterns to identify dosages of medications. In addition, the pack includes nearly 7,000 sentiment phrases identified from healthcare forum content, like joint swelling, back pain, and itchy skin.
"Our customers in the pharmaceutical industry have told us that they're inundated with unstructured data from social conversations, news media, surveys, and other text, and are looking for a way to make sense of it all and act on it," said Jeff Catlin, CEO of Lexalytics, in a statement. "With the Pharmaceutical Industry Pack, the latest in our series of industry-specific text analytics packages, we're excited to dramatically simplify the jobs of CEM and VOC pros, market researchers, and social marketers in this field."
"Lexalytics helped us sift through thousands of comments from medical professionals, enabling us to glean valuable insights," said Ryan Arnold, vice president of medical affairs at Sage Therapeutics, in a statement. "With the Pharmaceutical Industry Pack, we're able to find specific trends that we would otherwise have missed."